aInserm U1219, EPICENE, Cancer et expositions environnementales, Bordeaux University, Bordeaux
bANTICIPE, Normandy University, Unicaen, INSERM U1086, Caen
cEspace Régional de réflexion éthique, CHU de Caen, Université de Normandie, Caen
dCentre Régional de Coordination du Dépistage des Cancers (CRCDC), Bretagne
eCentre Régional de Coordination du Dépistage des Cancers (CRCDC), NormandieFrance
Received 5 July 2022 Accepted 31 October 2022.
This work was supported by the Gironde Regional Cancer League. We would like to thank the managers of the screening management structures involved in this project: Annick Notari, Christine Piette, Mathilde Cosson, Marie-Christine Quertier and Catherine Payet.
N.D, G.M. and S.D. designed the work; M.C. and M-C.Q. were responsible for the acquisition of the data for this work; N.D., M.P., G.M. and S.D. analysed the data. All authors contributed to their interpretation. N.D. M.P., G.M. and S.D. drafted the article. All authors provided revision of the article and approved the final version of the article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.eurjcancerprev.com).
Correspondence to Marie Poiseuil, PhD, Université Bordeaux, Inserm, Bordeaux Population Health, Research Center U1219, Equipe EPICENE, 146 rue Léo Saignat, 33076 Bordeaux, France, Tel: +33 5 57 57 45 10; e-mail: [email protected]
